Regeneron Pharmaceuticals | REGN - Рыночная капитализация

Биржевая цена
686.66
Изменение за день
-45.11 -6.16%
Ежемесячно
-8.36%
Ежегодный
14.68%
Q2 прогноз
735.49




Рыночная капитализация Изменить Дата
AbbVie USD 355.2B 48.64B 2026-04
Agenus USD 107M 16M 2025-12
Agios Pharmaceuticals USD 1.53B 57M 2026-04
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
Astellas Pharma JPY 4.13T 430.55B 2026-04
AstraZeneca USD 210.86B 90.39B 2026-04
Biogen USD 27.49B 589M 2026-04
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
GlaxoSmithKline GBP 78.79B 5.01B 2026-04
Incyte USD 21.96B 3.23B 2026-04
Ionis Pharmaceuticals USD 10.55B 1.91B 2026-04
J&J USD 561.65B 17.5B 2026-04
Kyowa Hakko Kirin JPY 1.33T 120.11B 2025-12
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 231.75B 76B 2026-04
Novartis USD 263.08B 17.01B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Regeneron Pharmaceuticals USD 75.46B 6.22B 2026-04
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 117.34B 2.45B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Teva Pharmaceutical Industries USD 107.27B 72.99B 2026-04
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12